Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
With this unmatched coverage, pharmaceutical manufacturers and healthcare researchers can move beyond traditional claims analysis to access verified insights that illuminate real-world treatment dynamics across diverse patient populations
Invest 124 , 42234226 (2014)
GLP-1 receptor activation in hypothalamic and brainstem appetite centers directly suppresses hunger and enhances satiety signaling
Employers investing in these treatments expect meaningful outcomes, and success depends on more than prescriptions
("resbiotic" or "res") resbiotic was founded in 2021 to bring physician-formulated dietary supplements to global consumers, harnessing the power of prebiotics, probiotics, postbiotics, and bioactive botanicals to conquer chronic struggles and promote proactive wellness